Within subject variability [Power / Sample Size]

posted by MaggieSantos – Portugal, 2018-03-15 23:51 (3027 d 05:40 ago) – Posting: # 18558
Views: 6,132

Dear all,

I am exploring the hypothesis to use the within subject variability obtained on conventional 2 way crossover bioequivalence study and apply it in scale average bioequivalence as described for a replicated design used for HVD or NTI.
I know that within subject variability of reference would be necessary, but I have no replicated design. My doubt is if these values have any relation somehow like, for instance, the first one is larger than the second one or there is no relationship at all?

Kind Regards

MaggieSantos

Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
313 visitors (0 registered, 313 guests [including 18 identified bots]).
Forum time: 06:32 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5